Reported Experience Measurement on Reducing Patient Discomfort in Intensive Care
Recruiting now · Not applicable
Conditions studied: PTSD - Post Traumatic Stress Disorder
In brief
Hospitalisation in intensive care is always traumatic and can lead to a long rehabilitation process, slowed down by symptoms of anxiety and/or depression, and/or post-traumatic stress disorder (PTSD). These psychiatric disorders, or post-intensive care syndrome (PICS), can persist for several years after hospitalisation in intensive care and cause functional disability. They are associated with the use of psychotropic drugs and mental health services, and impair health-related quality of life. This research is based on the hypothesis that the traumatic nature of intensive care hospitalisation can be reduced by implementing programmes to improve intensive care hospitalisation conditions, promoting changes in the practices of all healthcare professionals involved in intensive care. IPREA3 study (Kalfon et al, 2017) demonstrated that implementation of a tailor-made, multi-component programme, led by a doctor/non-medical caregiver significantly reduced the overall discomfort score (derived from the IPREA questionnaire) perceived by patients hospitalised in an intensive care unit with sufficient experience in applying this programme, having used it for at least 5 months (Kalfon et al, 2017) . The originality and interest of this research, in comparison with the IPREA3 study, lie in the following aspects: * the use of the most recent version of the IPREA questionnaire, * the questionnaire was completed by the patient themselves without the intervention of a caregiver (self-administration) * the fact that new care practices, aimed at humanising a stay in intensive care and making the experience of a stay in intensive care less traumatic, were described after the publication of the IPREA3 study a * a longer programme learning period of 9 months (compared to 5 months during the IPREA3 study) * the launch of the PREMREA programme with a conference led by a patient expert
Key facts
- Study ID
- NCT07525284
- Run by
- Almaviva Sante
- People needed
- 1242
- Starts
- 2025-12-19
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-04-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient, male or female, aged ≥ 18 years
- Patient discharged alive from intensive care
- Patient hospitalised in intensive care for at least three calendar days
- Patient affiliated with or beneficiary of a social security scheme
- Patient who speaks French and has signed an informed consent form
You may not qualify if…
- Patients whose situation is incompatible with completing the IPREA questionnaire
- Protected patients: adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision
- Patients hospitalised without consent
- Pregnant and/or breastfeeding women
Where it is running
- Hôpital Privé La Casamance — Aubagne, France, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.